UNIVERSITY OF WASHINGTON
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
Coping and Adjusting to Living With Multiple Sclerosis
Not Applicable
Completed
- Conditions
- Multiple Sclerosis
- Interventions
- Behavioral: CBT for Uncertainty ToleranceBehavioral: Traditional CBT
- First Posted Date
- 2020-03-09
- Last Posted Date
- 2023-06-23
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 242
- Registration Number
- NCT04300816
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)
Not Applicable
Active, not recruiting
- Conditions
- DementiaChronic DiseaseNeoplasm MetastasisLung NeoplasmsPulmonary Disease, Chronic ObstructiveHeart Failure, CongestiveLiver CirrhosisKidney Failure, ChronicLung Diseases, InterstitialPeripheral Vascular Disease
- Interventions
- Behavioral: Survey-based Patient/Clinician JumpstartBehavioral: EHR-based Clinician Jumpstart
- First Posted Date
- 2020-02-25
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 756
- Registration Number
- NCT04283994
- Locations
- 🇺🇸
Harborview Medical Center, Seattle, Washington, United States
🇺🇸UW Medical Center - Montlake, Seattle, Washington, United States
🇺🇸UW Medical Center - Northwest, Seattle, Washington, United States
Impact of Probiotics on Drug, Vitamin, and Hormone Metabolism
Not Applicable
- Conditions
- Metabolism
- Interventions
- Dietary Supplement: Visbiome
- First Posted Date
- 2020-02-24
- Last Posted Date
- 2020-02-24
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 12
- Registration Number
- NCT04281407
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
Not Applicable
Completed
- Conditions
- DementiaChronic DiseaseNeoplasm MetastasisLung NeoplasmPulmonary Disease, Chronic ObstructiveHeart Failure，CongestiveLiver CirrhosisKidney Failure, ChronicLung Diseases, InterstitialPeripheral Vascular Disease
- Interventions
- Behavioral: EHR-based Clinician Jumpstart
- First Posted Date
- 2020-02-24
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 2512
- Registration Number
- NCT04281784
- Locations
- 🇺🇸
UW Medical Center - Montlake (UWMC), Seattle, Washington, United States
🇺🇸Harborview Medical Center, Seattle, Washington, United States
🇺🇸UW Medical Center - Northwest, Seattle, Washington, United States
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
Phase 2
Recruiting
- Conditions
- Myelodysplastic SyndromeMyeloproliferative Neoplasm, UnclassifiablePrimary MyelofibrosisAcute Myeloid LeukemiaEssential ThrombocythemiaMyeloproliferative NeoplasmPolycythemia VeraSecondary MyelofibrosisMyelodysplastic/Myeloproliferative Neoplasm
- Interventions
- Other: Questionnaire Administration
- First Posted Date
- 2020-02-24
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 25
- Registration Number
- NCT04282187
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Collaborative Opioid Taper After Trauma: Preventing Opioid Misuse and Opioid Use Disorder
Not Applicable
- Conditions
- Opioid-use DisorderOpioid UsePain, PostoperativeTraumaOpioid Use, Unspecified
- Interventions
- Other: Provide assistance to subject's rural PCP pertaining to subject/patient pain management goals and opioid taper plan
- First Posted Date
- 2020-02-19
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 100
- Registration Number
- NCT04275258
- Locations
- 🇺🇸
Harborview Medical Center, Seattle, Washington, United States
Remote Ischemic Conditioning to Enhance Resuscitation (RICE) Pilot
Not Applicable
Completed
- Conditions
- Cardiac Arrest
- Interventions
- Device: Active Remote Ischemic ConditioningDevice: Sham Remote Ischemic Conditioning
- First Posted Date
- 2020-02-12
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 30
- Registration Number
- NCT04265807
- Locations
- 🇺🇸
Graham Nichol, Seattle, Washington, United States
Impact of Hypothalamic Gliosis on Appetite Regulation and Obesity Risk in Children
Completed
- Conditions
- Obesity, Childhood
- First Posted Date
- 2020-02-07
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 101
- Registration Number
- NCT04260048
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸University of Washington, Seattle, Washington, United States
Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma
Phase 1
Recruiting
- Conditions
- Primary Mediastinal (Thymic) Large B-Cell LymphomaB-Cell Non-Hodgkin LymphomaGrade 3a Follicular LymphomaTransformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh Grade B-Cell LymphomaGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma
- Interventions
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 50
- Registration Number
- NCT04257578
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Telehealth Pain Self-Management for Employed Adults
Not Applicable
Completed
- Conditions
- Multiple SclerosisBrain Injuries, TraumaticAmputationChronic PainSpinal Cord Injuries
- Interventions
- Behavioral: E-TIPS
- First Posted Date
- 2020-01-30
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 220
- Registration Number
- NCT04248725
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
© Copyright 2025. All Rights Reserved by MedPath